Miller, Eric D.
Hitchcock, Kathryn E.
Romesser, Paul B.
Funding for this research was provided by:
National Institutes of Health (P30 CA16058, P30 CA008748)
Article History
Accepted: 15 December 2022
First Online: 18 January 2023
Declarations
:
: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
: EDM has served as a consultant for Varian Medical Systems. KEH reports research relationships with Elekta, Merck, and BioMimetix that are unrelated to the topic of this review. PBR received research funding and serves as a consultant for EMD Serono, receives research funding from XRAD Therapeutics, is a consultant for Faeth therapeutics, and is a consultant for Natera.